藥物的組份 的英文怎麼說

中文拼音 [yàowùdezǔbīn]
藥物的組份 英文
pharmaceutic ingredient
  • 藥 : Ⅰ名詞1 （藥物） medicine; drug; remedy 2 （某些有化學作用的物質） certain chemicals Ⅱ動詞1 [書面...
  • 物 : 名詞1 （東西） thing; matter; object 2 （指自己以外的人或與己相對的環境） other people; the outsi...
  • 的 : 4次方是 The fourth power of 2 is direction
  • 組 : Ⅰ名詞1 （由不多的人員組成的單位） group 2 （姓氏） a surname Ⅱ動詞（組織） organize; form Ⅲ量詞（...
  • 藥物 : medicinal; medicine; medicant; medication; drug; pharmaceuticals; medicaments
  1. Yunnan jianyuan biological development co., ltd. in april 1999, pioneer, formerly yunnan tin hing biological development co., ltd., july 11, 2002, the following changes to their program yunnan jianyuan biological development co., ltd., a corporate shareholders ( yunnan son yuan, inc. ) and co - funded a seven natural shareholders, for the development of indian melia japonica is a biological pesticide, melia japonica japan, india india melia japonica supplies and medical supplies for biological research - led professional development company

    雲南建元生物開發有限公司始創於1999年4月，其前身為雲南天興生物開發有限公司， 2002年7月11日，經增資擴股后變更為雲南建元生物開發有限公司，由一個法人股東（雲南子元股份有限公司）及七個自然人股東共同出資組建，是一家以開發印楝生物農藥、印楝日化用品及印楝醫藥用品為主導的專業性生物研究開發公司。
  2. The market occupation of retapase project has been over appraised and the market orientation is based on self - reference while less weight has been put on market survey ; the project fund comes inadequately from self - raised resources or by transferring the techniques. in the organization framework of the project, the conventional linear system is adopted, which inhibit imbibing the wisdom of majority ; on personnel management, the r & d professionals have been weighed much more against the management professionals and little effort has been put on building the professionals reservoir, while the personnel incentive tactics are not conducive to the long benefit of the project in addition, the cost management is maldeveloped and the project progress controlling has been neglected

    瑞特普酶項目屬生物制藥項目，本文對fdzj公司瑞特普酶項目的管理現狀進行了詳細分析，具體有待改進地方有：市場份額估計過高，市場定位本位化，市場調查注重不足；項目融資僅採用自籌資金及科技成果轉讓的方式；項目組織結構為傳統的直線制，不利於集思廣義，人員配備重研發人才，輕管理人才，人才儲備工作欠缺，人員激勵策略與項目長遠利益不銜接；成本管理欠缺，忽視進度管理等。
  3. Lung volume reduction surgery was advocated ten years ago as the treatment for some of the patients with advanced emphysema who are already on maximal medical therapy. the theory behind this operation is that by removing the most emphysematous parts of the lungs, respiratory mechanics would improve

    十年前，肺減容手術（ lungvolumereductionsurgery ）被視為是對部份已接受最大劑量藥物治療的晚期肺氣腫病人的可行治療方法；手術是通過切除肺氣腫病變最嚴重的部份肺組織，從而使呼吸功能得到改善。
  4. Disorder of conductive hearing loss can usually be cured by medication or surgery. however, disorder of sensorineural hearing loss which is common to old age, cannot be relieved by medication or surgery and people suffering from moderate hearing loss of such kind will have to depend on hearing instruments to help them.

    （二）感音性弱聽因內耳、聽覺神經及中樞發生毛病而引致弱聽，例如年老關系、聽覺細胞及組織退化，藥物或手術對大部份感音性弱聽的人士都幫助不大。
  5. Yangzhou uni - bio pharmaceutical co., ltd, a joint shareholding enterprises formed by poultry institute, chinese academy of agricultural sciences and changzhou lihua livestock & poultry co., ltd, is a high - tech enterprises professional in research & development, production and marketing of biological products used in animal disease prevention and treatment

    揚州優邦生物制藥有限公司是由中國農業科學院家禽研究所與常州立華畜禽有限公司共同投資組建的股份制企業，是專業從事動物疫病預防、治療用生物製品的研發、生產和銷售的高新技術企業。
  6. When temperature lower than 30 ?, the fracture mode of j2 and j1 is mainly breaking of crystal mode, and at temperature of 45 ?,

    本文從三種高聚物粘結炸藥的組份及組份含量等方面對此規律性進行了分析與解釋。
  7. The total contract research organisation ( cro ) market is expected to reach $ 24bn ( ? 18bn ) by 2010 as biopharma companies ' spending on outsourcing serices continues to soar, new research reeals

    一項新的研究表明，由於生物制藥公司外包服務開銷持續高漲，合同研究組織（ cro ）總的市場份額到2010年將達250億美元（ 180億歐元） 。
分享友人
分享到 Line

分享到臉書